It’s not just money that is lacking. Successful development of medical therapeutics in Japan ー including vaccines ー takes transparency and ethical policies.
Japanese drugmaker Shionogi & Co. looks to meet domestic demand, as countries worldwide scramble for supplies of Pfizer and Merck drugs.
